APOA1 and myeloid sarcoma: In the next set of experiments, we reported that the mRNA level of APOA1 transcript was significantly lower both in platelets (approximately 1.5-fold) and megakaryocytes (near 12-fold) from SP MS patients compared to the control group (p < 0.001; p < 0.0001, respectively) (Figure 4A,B).